Global Payments Announces Agreement to Divest Payroll Business
ATLANTA--(BUSINESS WIRE)--Global Payments Inc. (NYSE: GPN), a leading worldwide provider of payment technology and software solutions, announced today that it has entered into a definitive agreement to divest its Payroll business to Acrisure, a financial technology company based in Grand Rapids, Michigan for total consideration of $1.1 billion.
The divestiture of its Payroll business is the latest step Global Payments has taken to further simplify its business and position the company as a leading pure play commerce solutions provider for merchants of all sizes.
Global Payments intends to use the after-tax proceeds from the divestiture to return capital to shareholders while maintaining leverage neutrality.
The divestiture of its Payroll business is the latest step Global Payments has taken to further simplify its business and position the company as a leading pure play commerce solutions provider for merchants of all sizes. As part of the transformation program outlined at its September 2024 Investor Conference, Global Payments also recently announced agreements to divest its Issuer Solutions business and acquire Worldpay, and closed its sale of AdvancedMD.
"I am pleased with the progress we are making with our transformation program as we move aggressively to simplify our business and enhance value for shareholders," said Cameron Bready, CEO of Global Payments. "This transaction further sharpens our strategic focus and allows us to amplify investment in the markets and solutions where we are most differentiated, while also positioning the payroll business to benefit from greater scale and investment moving forward."
In connection with the transaction, Global Payments entered into a mutual referral agreement and long-term commercial partnership with Acrisure in which Global Payments will continue delivering fully integrated human capital management and payroll offerings to its merchant customers as part of its suite of commerce enablement solutions.
The transaction is expected to close in the second half of 2025, subject to the receipt of required regulatory approvals and other customary closing conditions.
About Global Payments
Global Payments (NYSE: GPN) helps businesses around the world enable commerce and provide exceptional experiences to their customers. Our payment technology and software solutions enable merchants, issuers and developers to deliver seamless customer experiences, run smarter operations and adapt quickly to change. Because if it has anything to do with commerce, we are already on it.
With 27,000 team members across 38 countries, we have the scale and expertise to help businesses grow with confidence. Headquartered in Georgia, Global Payments is a Fortune 500® company and a member of the S&P 500.
Learn more at company.globalpayments.com and follow us on X, LinkedIn and Facebook.
Forward-Looking Statements
This communication may contain certain forward-looking statements within the meaning of the 'safe-harbor' provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on current expectations, estimates and projections about the industry and markets in which we operate, and beliefs of and assumptions made by our management, involve risks, uncertainties and assumptions that could significantly affect the financial condition, results of operations, business plans and the future performance of Global Payments. Actual events or results might differ materially from those expressed or forecasted in these forward-looking statements. Accordingly, we cannot guarantee that our plans and expectations will be achieved. Examples of forward-looking statements include, but are not limited to, statements we make regarding future financial and operating results, including revenue, earnings estimates, liquidity, and deleveraging plans, management's expectations regarding future plans, objectives and goals; market and growth opportunities; capital available for allocation; the effects of general economic conditions on our business; statements about the strategic rationale and anticipated benefits of acquisitions or dispositions, such as the proposed dispositions of the Payroll and Issuer Solutions businesses or the proposed acquisition of Worldpay (the 'Transactions'), including future financial and operating results, and the successful integration of our acquisitions; statements about the completion of anticipated benefits and strategic or operational initiatives; statements regarding our success and timing in developing and introducing new services and expanding our business; and other statements regarding our future financial performance and the company's plans, objectives, expectations and intentions. Statements can generally be identified as forward-looking because they include words such as 'believes,' 'anticipates,' 'expects,' 'intends,' 'plan,' 'forecast,' 'could,' 'should,' 'will,' 'would,' or words of similar meaning. Although we believe that the plans and expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our plans and expectations will be attained, and therefore actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements.
In addition to factors previously disclosed in Global Payments' reports filed with the SEC and those identified elsewhere in this presentation, the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance: Global Payments' ability to complete the proposed Transactions on the proposed terms or on the anticipated timelines, or at all; failing to fully realize anticipated cost savings and other anticipated benefits of the proposed Transactions when expected or at all; business disruptions from the proposed Transactions that will harm Global Payments' businesses, including current plans and operations; the diversion of management's attention from ongoing business operations; the continued availability of capital and financing; the effects of global economic, political, market, health and social events or other conditions; the imposition of tariffs and other trade policies and the resulting impacts on market volatility and global trade; macroeconomic pressures and general uncertainty regarding the overall future economic environment; foreign currency exchange, inflation and rising interest rate risks; the effects of a security breach or operational failure on our business; the ability to maintain Visa and Mastercard registration and financial institution sponsorship; difficulties, increased competition in the markets in which we operate and our ability to increase our market share in existing markets and expand into new markets; our ability to safeguard our data; risks associated with our indebtedness; the potential effect of climate change including natural disasters; the effects of new or changes in current laws, regulations, credit card association rules or other industry standards on us or our partners and customers, including privacy and cybersecurity laws and regulations; and other events beyond our control, and other factors included in the 'Risk Factors' section in our most recent Annual Report on Form 10-K and in other documents that we file with the SEC, which are available at https://www.sec.gov.
These cautionary statements qualify all of our forward-looking statements, and you are cautioned not to place undue reliance on these forward-looking statements. Our forward-looking statements speak only as of the date they are made and should not be relied upon as representing our plans and expectations as of any subsequent date. While we may elect to update or revise forward-looking statements at some time in the future, we specifically disclaim any obligation to publicly release the results of any revisions to our forward-looking statements, except as required by law.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Amphenol Corporation Announces Pricing of USD-Denominated Senior Notes Offering
WALLINGFORD, Conn., June 09, 2025--(BUSINESS WIRE)--Amphenol Corporation (NYSE: APH) (the "Company") announced today the pricing of its offering of $750 million aggregate principal amount of senior notes due 2028 (the "USD Notes"). The USD Notes will have an interest rate of 4.375% per annum. The closing of the offering of USD Notes (the "USD Notes Offering") is expected to occur on June 12, 2025, subject to the satisfaction of customary closing conditions. Substantially concurrently with or shortly after the USD Notes Offering, the Company expects to offer, by means of a separate prospectus supplement, euro-denominated notes (the "Euro Notes"). Neither the completion of the USD Notes Offering nor the offering of the Euro Notes (the "Euro Notes Offering") is contingent on the completion of the other. Therefore, it is possible that the USD Notes Offering is completed and the Euro Notes Offering is not completed. The Company intends to use the net proceeds from the USD Notes Offering and the Euro Notes Offering to repay borrowings under the Company's U.S. commercial paper program and for general corporate purposes. Citigroup Global Markets Inc., Mizuho Securities USA LLC and TD Securities (USA) LLC are serving as the joint book-running managers for the USD Notes Offering. The USD Notes are being offered pursuant to the Company's effective shelf registration statement on file with the Securities and Exchange Commission (the "SEC"). A prospectus supplement describing the terms of this offering will be filed with the SEC. Copies of the prospectus supplement and accompanying prospectus for the offering may be obtained from Citigroup Global Markets Inc. toll-free at 1-800-831-9146, Mizuho Securities USA LLC toll-free at 1-866-271-7403 and TD Securities (USA) LLC toll-free at 1-855-495-9846. This press release does not constitute an offer to sell or the solicitation of an offer to buy the USD Notes, nor will there be any sale of the USD Notes, in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any offer, solicitation or sale of the USD Notes will be made only by means of the prospectus supplement and the accompanying prospectus. About Amphenol Amphenol Corporation is one of the world's largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 countries around the world and sells its products through its own global sales force, independent representatives and a global network of electronics distributors. Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Commercial Aerospace, Communications Networks, Defense, Industrial, Information Technology and Data Communications and Mobile Devices. For more information, visit Forward-Looking Statements Statements in this press release which are other than historical facts are intended to be "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, the Private Securities Litigation Reform Act of 1995 and other related laws. While the Company believes such statements are reasonable, the actual results and effects could differ materially from those currently anticipated. Details regarding various significant risks and uncertainties that may affect our operating and financial performance can be found in the Company's latest Annual Report on Form 10-K and the Company's subsequent filings with the Securities and Exchange Commission, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. In providing forward-looking statements, the Company is not undertaking any duty or obligation to update these statements publicly as a result of new information, future events or otherwise, except as required by law. View source version on Contacts Sherri ScribnerVice President, Strategy and Investor Relations203-265-8820IR@
Yahoo
16 minutes ago
- Yahoo
U.S. Court of Appeals for the Federal Circuit Affirms Prior Delaware District Court Rulings in Favor of Acadia in NUPLAZID® (pimavanserin) Composition of Matter Patent
- Composition of matter patent affirmed, provides protection into 2030 - Builds on recent ruling in favor of Acadia for formulation patent expiring in 2038 SAN DIEGO, June 09, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. Court of Appeals for the Federal Circuit affirmed a decision issued by the U.S. District Court for the District of Delaware in December 2023 confirming validity of the NUPLAZID® (pimavanserin) '740 composition of matter patent. The affirmance came in Acadia's litigation against MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals, Inc. In its affirmance, the Appeals Court applied the precedent established in Allergan USA, Inc. v. MSN Laboratories Private Ltd., MSN Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, holding that "a first filed, first-issued, later-expiring claim cannot be invalidated by a later-filed, later-issued, earlier-expiring reference claim having a common priority date." "We are gratified that the U.S. Federal Appeals Court has affirmed the lower court's ruling in favor of our composition of matter patent for NUPLAZID, securing protection into 2030 for this patent, and beyond based on the recent favorable ruling for our formulation patent providing patent protection for NUPLAZID 34 mg capsule formulation into 2038," said Catherine Owen Adams, Chief Executive Officer. "These decisions reinforce our commitment to safeguarding the intellectual property that underpins our innovations in addressing serious, unmet medical needs." This follows the U.S. District Court for the District of Delaware ruling in favor of Acadia regarding its '721 formulation patent for NUPLAZID which ruled in favor of Acadia on both infringement and validity arguments in its formulation patent litigation against Aurobindo Pharma Limited and other ANDA (Abbreviated New Drug Application) filers. About Acadia Pharmaceuticals Acadia is advancing breakthroughs in neuroscience to elevate life. Since our founding we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson's disease psychosis and the first and only approved drug in the United States and Canada for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on Prader-Willi syndrome, Alzheimer's disease psychosis and multiple other programs targeting neuroscience and neuro-rare diseases. For more information, visit us at and follow us on LinkedIn and X. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements other than statements of historical fact and can be identified by terms such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "estimates," "projects," "predicts," "potential," "continue" and similar expressions (including the negative thereof) intended to identify forward-looking statements. Forward-looking statements contained in this press release, include, but are not limited to, statements about: (i) the impact of the court ruling on our business and our ability to defend ourselves in the future; (ii) the continued patent protection for NUPLAZID; and (iii) the anticipated timing for termination of such protections. Forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause our actual results, performance or achievements to differ materially and adversely from those anticipated or implied by our forward-looking statements. Such risks, uncertainties and other factors include, but are not limited to: our ability to maintain, protect and enhance our intellectual property; the outcome of other existing and potential future lawsuits challenging our intellectual property; and our ability to continue to stay in compliance with applicable laws and regulations. Given the risks and uncertainties, you should not place undue reliance on these forward-looking statements. For a discussion of these and other risks, uncertainties and other factors that may cause our actual results, performance or achievements to differ, please refer to our annual report on Form 10-Q for the quarter ended March 31, 2025 as well as our subsequent filings with the Securities and Exchange Commission from time to time. The forward-looking statements contained herein are made as of the date hereof, and we undertake no obligation to update them after this date, except as required by law. View source version on Contacts Investor Contacts: Acadia Pharmaceuticals Kildani(858) 261-2872ir@ Acadia Pharmaceuticals Tieszen(858) 261-2950ir@ Media Contact: Acadia Pharmaceuticals Kazenelson(818) 395-3043media@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
21 minutes ago
- Business Wire
Amphenol Corporation Announces Pricing of USD-Denominated Senior Notes Offering
WALLINGFORD, Conn.--(BUSINESS WIRE)--Amphenol Corporation (NYSE: APH) (the 'Company') announced today the pricing of its offering of $750 million aggregate principal amount of senior notes due 2028 (the 'USD Notes'). The USD Notes will have an interest rate of 4.375% per annum. The closing of the offering of USD Notes (the 'USD Notes Offering') is expected to occur on June 12, 2025, subject to the satisfaction of customary closing conditions. Substantially concurrently with or shortly after the USD Notes Offering, the Company expects to offer, by means of a separate prospectus supplement, euro-denominated notes (the 'Euro Notes'). Neither the completion of the USD Notes Offering nor the offering of the Euro Notes (the 'Euro Notes Offering') is contingent on the completion of the other. Therefore, it is possible that the USD Notes Offering is completed and the Euro Notes Offering is not completed. The Company intends to use the net proceeds from the USD Notes Offering and the Euro Notes Offering to repay borrowings under the Company's U.S. commercial paper program and for general corporate purposes. Citigroup Global Markets Inc., Mizuho Securities USA LLC and TD Securities (USA) LLC are serving as the joint book-running managers for the USD Notes Offering. The USD Notes are being offered pursuant to the Company's effective shelf registration statement on file with the Securities and Exchange Commission (the 'SEC'). A prospectus supplement describing the terms of this offering will be filed with the SEC. Copies of the prospectus supplement and accompanying prospectus for the offering may be obtained from Citigroup Global Markets Inc. toll-free at 1-800-831-9146, Mizuho Securities USA LLC toll-free at 1-866-271-7403 and TD Securities (USA) LLC toll-free at 1-855-495-9846. This press release does not constitute an offer to sell or the solicitation of an offer to buy the USD Notes, nor will there be any sale of the USD Notes, in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any offer, solicitation or sale of the USD Notes will be made only by means of the prospectus supplement and the accompanying prospectus. About Amphenol Amphenol Corporation is one of the world's largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 countries around the world and sells its products through its own global sales force, independent representatives and a global network of electronics distributors. Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Commercial Aerospace, Communications Networks, Defense, Industrial, Information Technology and Data Communications and Mobile Devices. For more information, visit Forward-Looking Statements Statements in this press release which are other than historical facts are intended to be 'forward-looking statements' within the meaning of the Securities Exchange Act of 1934, as amended, the Private Securities Litigation Reform Act of 1995 and other related laws. While the Company believes such statements are reasonable, the actual results and effects could differ materially from those currently anticipated. Details regarding various significant risks and uncertainties that may affect our operating and financial performance can be found in the Company's latest Annual Report on Form 10-K and the Company's subsequent filings with the Securities and Exchange Commission, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. In providing forward-looking statements, the Company is not undertaking any duty or obligation to update these statements publicly as a result of new information, future events or otherwise, except as required by law.
